companydata.dkcompanydata.dk

ZEALAND PHARMA A/S: Financial statements 2021

CVR: 20045078

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

ZEALAND PHARMA A/S (CVR 20045078) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 292,567,000 and a net result of DKK -1,018,149,000 compared with DKK -846,729,000 the year before. That is a decrease of 17.2% compared with the year before. The profit margin was -348%. Equity in the 2021 report amounted to DKK 927,803,000. The solvency ratio was 44.9%. The company had 346 employees in the financial year.

Revenue
DKK 292,567,000
Gross Profit
DKK 173,753,000
Profit/Loss
DKK -1,018,149,000
Equity
DKK 927,803,000
Total Assets
DKK 2,067,629,000
Employees
346

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021292.6M173.8M-1B927.8M346
2020353.3M262.7M-846.7M1.2B297
201941.3M--571.5M1.2B-
201838M-581.3M1.1B-
2017139.8M--272.3M528.5M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ZEALAND PHARMA A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

ZEALAND PHARMA A/S publishes interim reportDec 8, 2021

ZEALAND PHARMA A/S has published its interim report for the period January 1, 2021 to September 30, 2021.

ZEALAND PHARMA A/S publishes interim reportNov 22, 2021

ZEALAND PHARMA A/S has published its interim report for the period January 1, 2021 to June 30, 2021.

Anneline Nansen joins the board of ZEALAND PHARMA A/SSep 1, 2021

As of September 1, 2021, Anneline Nansen has joined the board of directors of ZEALAND PHARMA A/S.

Gertrud Koefoed Rasmussen leaves the board of ZEALAND PHARMA A/SSep 1, 2021

As of September 1, 2021, Gertrud Koefoed Rasmussen has left the board of directors of ZEALAND PHARMA A/S.

Anneline Nansen leaves the board of ZEALAND PHARMA A/SAug 31, 2021

As of August 31, 2021, Anneline Nansen has left the board of directors of ZEALAND PHARMA A/S.

ZEALAND PHARMA A/S: The 2020 annual report is outApr 21, 2021

ZEALAND PHARMA A/S has published its annual report for 2020. Revenue came to DKK 353,314,000, and the net result was DKK -846,729,000.

About ZEALAND PHARMA A/S

ZEALAND PHARMA A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1997. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ZEALAND PHARMACEUTICALS A/S and PEPTIDE PROBE TECHNOLOGIES ApS. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The board consists of Alf Gunnar Martin Nicklasson (chair), Kirsten Aarup Drejer, Adam Krisko Nygaard and Anneline Nansen. The company's owners include ZEALAND PHARMA A/S, Van Herk Investments B.V. and Van Herk Management Services B.V.. The company has 575 employees (2026). In 2025, the company reported revenue of DKK 9,214,860,000 and a net result of DKK 6,455,008,000 compared with DKK -1,078,828,000 the year before. Equity in the 2025 report amounted to DKK 14,830,613,000.

Source: annual report 2025, Danish Business Authority